Embed presentation
Download to read offline













Merck announced financial results for Q4 and full-year 2008. Q4 non-GAAP EPS was $0.87 excluding restructuring charges, and GAAP EPS was $0.78. Full-year 2008 non-GAAP EPS was $3.42 excluding certain items, and GAAP EPS was $3.64. Worldwide sales for Q4 2008 decreased 3% to $6 billion, and decreased 1% to $23.9 billion for full-year 2008. Merck reaffirmed its 2009 non-GAAP EPS guidance of $3.15-$3.30 excluding certain items, and GAAP EPS guidance of $2.95-$3.17. Newer products like J












